@prefix this: <
http://www.tkuhn.ch/bel2nanopub/RAhOGzPh43t0qrYGDm5AzBzA0kLOW8tz2AhAjCQ0AB1n4
> .
@prefix sub: <
http://www.tkuhn.ch/bel2nanopub/RAhOGzPh43t0qrYGDm5AzBzA0kLOW8tz2AhAjCQ0AB1n4#
> .
@prefix beldoc: <
http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel
> .
@prefix rdfs: <
http://www.w3.org/2000/01/rdf-schema#
> .
@prefix xsd: <
http://www.w3.org/2001/XMLSchema#
> .
@prefix dct: <
http://purl.org/dc/terms/
> .
@prefix dce: <
http://purl.org/dc/elements/1.1/
> .
@prefix pav: <
http://purl.org/pav/
> .
@prefix np: <
http://www.nanopub.org/nschema#
> .
@prefix prov: <
http://www.w3.org/ns/prov#
> .
@prefix obo: <
http://purl.obolibrary.org/obo/
> .
@prefix Protein: <
http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080
> .
@prefix hgnc: <
http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=
> .
@prefix geneProductOf: <
http://purl.obolibrary.org/obo/RO_0002204
> .
@prefix hasPart: <
http://purl.obolibrary.org/obo/BFO_0000051
> .
@prefix ProteinComplex: <
http://amigo.geneontology.org/amigo/term/GO:0043234
> .
@prefix occursIn: <
http://purl.obolibrary.org/obo/BFO_0000066
> .
@prefix species: <
http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=
> .
@prefix pubmed: <
http://www.ncbi.nlm.nih.gov/pubmed/
> .
@prefix orcid: <
http://orcid.org/
> .
sub:Head
{
this:
np:hasAssertion
sub:assertion
;
np:hasProvenance
sub:provenance
;
np:hasPublicationInfo
sub:pubinfo
;
a
np:Nanopublication
.
}
sub:assertion
{
sub:_1
hasPart:
hgnc:5981
,
sub:_2
;
occursIn:
obo:CL_0000842
,
species:9606
;
a
ProteinComplex:
.
sub:_2
geneProductOf:
hgnc:9955
;
a
Protein:
.
sub:assertion
rdfs:label
"complex(p(HGNC:RELA),g(HGNC:IL17A))" .
}
sub:provenance
{
beldoc:
dce:description
"Approximately 61,000 statements." ;
dce:rights
"Copyright (c) 2011-2012, Selventa. All rights reserved." ;
dce:title
"BEL Framework Large Corpus Document" ;
pav:authoredBy
sub:_4
;
pav:version
"20131211" .
sub:_3
prov:value
"Incubation of nuclear extracts from peripheral blood mononuclear cells with anti-CD23 plus CD28 demonstrated increased binding of NFKB to IL17 promoters with shifted bands in p50 and p65. But treatment with LY294002 and PTDC, inhibitors of PI3K and NFkB, completely blocked the NFkB binding activity in the IL-17 promoter, indicating that CD3 and CD28 induced the translocation of p50-NFkB and increased its binding with the IL-17 promoter." ;
prov:wasQuotedFrom
pubmed:15642134
.
sub:_4
rdfs:label
"Selventa" .
sub:assertion
prov:hadPrimarySource
pubmed:15642134
;
prov:wasDerivedFrom
beldoc:
,
sub:_3
.
}
sub:pubinfo
{
this:
dct:created
"2014-07-03T14:32:37.452+02:00"^^
xsd:dateTime
;
pav:createdBy
orcid:0000-0001-6818-334X
,
orcid:0000-0002-1267-0234
.
}